Magmedi

Magmedi is a magnesium supplement developed and marketed by KoRa Healthcare, containing 97.2 mg (4 mmol) of elemental magnesium in the form of magnesium citrate nonahydrate per tablet. It is indicated for the treatment and prevention of magnesium deficiency in adults, adolescents, and children aged 12 years and older. The product is regulated differently across regions: it is classified as a Natural Health Product (NHP) in Canada and as a Prescription Only Medicine (POM) in the United Kingdom and Ireland (where it is primarily marketed as Magnesium Kora Healthcare). As a mineral supplement, it works by replenishing systemic magnesium levels, which is essential for over 300 enzymatic reactions, including those involved in protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation.

Brand names

MagmediMagnesium Kora Healthcare

Other names

magnesium citrate nonahydratemagnesium citrate